Solventum Corp | SOLV - Equity Capital And Reserves


Solventum Corp reported $4.99B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Abbott USD 50.83B 0 Sep/2025
Align Technology USD 3.96B 44.68M Sep/2025
Baxter International USD 7.24B 79M Sep/2025
Becton, Dickinson and Co. USD 25.39B 82M Sep/2025
Cencora USD 1.91B 400.31M Dec/2025
Dexcom USD 2.73B 153M Sep/2025
Insulet USD 1.38B 78.8M Sep/2025
Solventum Corp USD 4.99B 1.34B Sep/2025
West Pharmaceutical Services USD 3.05B 122.4M Sep/2025
Zimmer Biomet Holdings USD 12.77B 231.7M Sep/2025